Severe cutaneous adverse drugs reactions associated with the use of oxicams: a case/non case study from the World Health Organization adverse drug reaction database

被引：0
|
作者：
Clarivet, B. [1 ]
Bres, V. [1 ]
Philibert, C. [1 ]
Trouilleux, C. [1 ]
Mathieu, O. [2 ]
Hillaire-Buys, D. [1 ]
Faillie, J. L. [1 ]
机构：
[1] Montpellier Univ Hosp, Dept Med Pharmacol & Toxicol, Pharmacovigilance Reg Ctr, Montpellier, France
[2] Montpellier Univ Hosp, Dept Med Pharmacol & Toxicol, Montpellier, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-058
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [1] Bladder cancers associated with gliflozin use: a case/non-case analysis in the World Health Organization's adverse drug reactions database
    Da Silva, S.
    Clarivet, B.
    Bres, V.
    Hillaire-Buys, D.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 52 - 52
  • [2] Use of Antiepileptic Drugs and the Risk of Severe Cutaneous Adverse Drug Reactions in Elderly Patients: A Nationwide Case-Control Study
    Kim, Ji Young
    Ko, Young-Jin
    Shin, Ju-Young
    Lee, Joongyub
    Jung, Sun-Young
    Choi, Nam-Kyong
    Park, Byung-Joo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 169 - 169
  • [3] Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
    Li, Dongxuan
    Gou, Jinghui
    Zhu, Jun
    Zhang, Tongyan
    Liu, Feng
    Zhang, Daojun
    Dai, Liyang
    Li, Wenjun
    Liu, Qinglong
    Qin, Chunmeng
    Du, Qian
    Liu, Songqing
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [4] Incretin-based drugs and pancreatic cancer: an analysis of the World Health Organization adverse drug reaction database
    Clarivet, B.
    Robin, P.
    Trouilleux, C.
    Foglia, K.
    Hillaire-Buys, D.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 25 - 26
  • [5] Statin-associated psychiatric adverse events: A case/non case evaluation of an Italian database of spontaneous reporting of adverse drug reactions
    Tuccori, M.
    Moretti, U.
    Lapi, F.
    Coli, D.
    Testi, A.
    Moschini, M.
    Vannocci, A.
    Blandizzi, C.
    Mugelli, A.
    Del Tacca, M.
    DRUG SAFETY, 2007, 30 (10) : 941 - 941
  • [6] Adverse drug reactions associated with ivermectin use for COVID19 reported in the World Health Organization's pharmacovigilance database
    Campillo, Jeremy T.
    Faillie, Jean-Luc
    THERAPIE, 2022, 77 (06): : 747 - 749
  • [7] Severe cutaneous adverse reactions associated with the immune checkpoint inhibitors: A case/non-case analysis using the Food and Drug Administration Adverse Event Reporting System
    Godfrey, Hannah
    Jedlowski, Patrick
    Thiede, Rebecca
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (03) : 243 - 253
  • [8] Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database
    Montastruc, Jean-Louis
    Lafaurie, Margaux
    de Canecaude, Claire
    Durrieu, Genevieve
    Sommet, Agnes
    Montastruc, Francois
    Bagheri, Haleh
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4334 - 4340
  • [9] Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study
    Greil, Waldemar
    Zhang, Xueqiong
    Stassen, Hans
    Grohmann, Renate
    Bridler, Rene
    Hasler, Gregor
    Toto, Sermin
    Bleich, Stefan
    Kasper, Siegfried
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (01) : 111 - 121
  • [10] Myositis associated with Immune Checkpoint Inhibitors: A pharmacovigilance study using the World Health Organization's adverse drug reactions database
    Ladhari, C.
    Nguyen, T.
    Maria, A.
    Palassin, P.
    Quantin, X.
    Lesage, C.
    Taieb, G.
    Ayrignac, X.
    Rullier, P.
    Lambotte, O.
    Guilpain, P.
    Hillaire-Buys, D.
    Faillie, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 103 - 103
12345